口服抗血小板治疗的未来：四个具有挑战性的假说。 - Suppr

Future of oral antiplatelet therapy: four challenged hypotheses.

作者信息

Serebruany Victor L, Makarov Leonid M

机构信息

HeartDrug Research Laboratories, Johns Hopkins University, Osler Medical Building, 7600 Osler Drive, Suite 307, Towson, Maryland, 21204, USA.

出版信息

Thromb Haemost. 2009 Jun;101(6):1041-3.

PMID:19492145

Abstract

摘要

相似文献

Future of oral antiplatelet therapy: four challenged hypotheses.

Thromb Haemost. 2009 Jun;101(6):1041-3.

[Prasugrel for acute and long-term treatment of patients with acute coronary syndromes: what is state-of-the-art?].

Dtsch Med Wochenschr. 2011 Apr;136(15):782-5. doi: 10.1055/s-0031-1272567. Epub 2011 Mar 22.

The TRITON versus PLATO trials: differences beyond platelet inhibition.

Thromb Haemost. 2010 Feb;103(2):259-61. doi: 10.1160/TH09-10-0695. Epub 2009 Dec 18.

[Prodrug activation as a crucial difference. Prasugrel - a new ADP receptor antagonist].

Pharm Unserer Zeit. 2009;38(4):320-8. doi: 10.1002/pauz.200900321.

Platelet P2 receptors: old and new targets for antithrombotic drugs.

Expert Rev Cardiovasc Ther. 2007 Jan;5(1):45-55. doi: 10.1586/14779072.5.1.45.

Prasugrel.

Circulation. 2010 Jul 27;122(4):394-403. doi: 10.1161/CIRCULATIONAHA.109.921502.

Study design and rationale of a comparison of prasugrel and clopidogrel in medically managed patients with unstable angina/non-ST-segment elevation myocardial infarction: the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes (TRILOGY ACS) trial.

Am Heart J. 2010 Jul;160(1):16-22.e1. doi: 10.1016/j.ahj.2010.04.022.

Early and late benefits of prasugrel in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a TRITON-TIMI 38 (TRial to Assess Improvement in Therapeutic Outcomes by Optimizing Platelet InhibitioN with Prasugrel-Thrombolysis In Myocardial Infarction) analysis.

J Am Coll Cardiol. 2008 May 27;51(21):2028-33. doi: 10.1016/j.jacc.2008.04.002.

[Pharmazie in unserer Zeit 4/2009].

Pharm Unserer Zeit. 2009;38(4):295. doi: 10.1002/pauz.200990042.

Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.

Prescrire Int. 2009 Oct;18(103):193-5.

引用本文的文献

[Old and new anticoagulants. Antidotes and measures for acute hemorrhaging and urgent interventions].

Anaesthesist. 2010 Jan;59(1):62, 64-8. doi: 10.1007/s00101-009-1645-6.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Future of oral antiplatelet therapy: four challenged hypotheses.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Future of oral antiplatelet therapy: four challenged hypotheses.

作者信息

机构信息

出版信息

相似文献

引用本文的文献